參考文獻(xiàn)/References:
[1] HARRELL C R,MARKOVIC B S,FELLABAUM C,et al.Mesenchymal stem cell-based therapy of osteoarthritis:Current knowledge and future perspectives[J].Biomed Pharmacother,2019,109:2318-2326.
[2] 王斌,邢丹,董圣杰,等.中國膝骨關(guān)節(jié)炎流行病學(xué)和疾病負(fù)擔(dān)的系統(tǒng)評價(jià)[J].中國循證醫(yī)學(xué)雜志,2018,18(2):134-142.
[3] 張紫嫣,黃雅薇,張新雪,等.“腎髓系統(tǒng)”的理論淵源[J].世界科學(xué)技術(shù)-中醫(yī)藥現(xiàn)代化,2017,19(5):744-748.
[4] 張榮華,歐陽菁.腎主骨生髓理論與骨髓間充質(zhì)干細(xì)胞骨向分化[J].中醫(yī)雜志,2006,47(10):730-732.
[5] 王連,侯鵬,蔣濤,等.不同來源間充質(zhì)干細(xì)胞在膝關(guān)節(jié)軟骨修復(fù)中的臨床研究進(jìn)展[J].中國骨傷,2017,30(6):581-586.
[6] 胡雪琴,金紅婷,肖魯偉,等.“浙派中醫(yī)”骨傷學(xué)家肖魯偉辨治“髓系骨病”的學(xué)術(shù)經(jīng)驗(yàn)[J].浙江中醫(yī)藥大學(xué)學(xué)報(bào),2019,43(10):1071-1073.
[7] 卞琴,沈自尹,王擁軍.骨髓間充質(zhì)干細(xì)胞在中醫(yī)理論中的歸屬[J].中國中醫(yī)基礎(chǔ)醫(yī)學(xué)雜志,2011,17(7):794-797.
[8] 張進(jìn),徐志偉,陳群,等.干細(xì)胞與中醫(yī)基礎(chǔ)理論中的先天之精學(xué)說[J].中國臨床康復(fù),2006,10(7):189-192.
[9] 劉幸明,趙永杰,蔡俊笙,等.補(bǔ)腎中藥對老化間充質(zhì)干細(xì)胞內(nèi)外微環(huán)境改變及其分化方向調(diào)控的影響[J].中成藥,2019,41(9):2233-2236.
[10] 劉鋅,杜斌,孫光權(quán),等.右歸飲誘導(dǎo)骨髓間充質(zhì)干細(xì)胞修復(fù)兔激素型股骨頭壞死的實(shí)驗(yàn)研究[J].世界中西醫(yī)結(jié)合雜志,2019,14(6):809-814.
[11] XIA C,ZOU Z,FANG L,et al.Bushenhuoxue formula promotes osteogenic differentiation of growth plate chondrocytes through β-catenin-dependent manner during osteoporosis[J].Biomed Pharmacother,2020,127:110.
[12] 胡雪琴,金紅婷,施振宇,等.髓病理論及其在骨病學(xué)中的應(yīng)用[J].中醫(yī)正骨,2018,30(11):39-42.
[13] 沈自尹.“腎的研究”通過“與時(shí)俱進(jìn)”而不斷進(jìn)取[J].中國中西醫(yī)結(jié)合雜志,2015,35(8):946-949.
[14] XU T T,JIN H T,TONG P J.Essence of “Shen(Kidney)controlling bones”:conceptual analysis based on hypothalamic-pituitary-adrenal-osteo-related cells axis[J].Chin J Integr Med,2018,24(11):806-808.
[15] WEIVODA M M,RUAN M,HACHFELD C M,et al.Wnt signaling inhibits osteoclast differentiation by activating canonical and noncanonical cAMP/PKA pathways[J].J Bone Miner Res,2016,31(1):65-75.
[16] ELANGO J,RAHMAN S U,HENROTIN Y,et al.Parathyroid hormone-related protein(PTHrP)accelerates soluble RANKL signals for downregulation of osteogenesis of bone mesenchymal stem cells[J].J Clin Med,2019,8(6):836.
[17] TIERNEY E G,MCSORLEY K,HASTINGS C L,et al.High levels of ephrinB2 over-expression increases the osteogenic differentiation of human mesenchymal stem cells and promotes enhanced cell mediated mineralisation in a poly-ethyleneimine-ephrinB2 gene-activated matrix[J].J Control Release,2013,165(3):173-182.
[18] CRANE J L,CAO X.Bone marrow mesenchymal stem cells and TGF-β signaling in bone remodeling[J].J Clin Inves,2014,124(2):466-472.
[19] 孫雪蓮,劉淵.從中醫(yī)“腎主骨”理論出發(fā)防治骨關(guān)節(jié)炎[J].西部中醫(yī)藥,2016,29(3):48-50.
[20] CAMERNIK K,MIHELIC A,MIHALIC R,et al.Comprehensive analysis of skeletal muscle- and bone-derived mesenchymal stem/stromal cells in patients with osteoarthritis and femoral neck fracture[J].Stem Cell Res Ther,2020,11(1):146.
[21] MCGONAGLE D,BABOOLAL T G,JONES E.Native joint-resident mesenchymal stem cells for cartilage repair in osteoarthritis[J].Nat Rev Rheumatol,2017,13(12):719-730.
[22] BARNETT R.Osteoarthritis[J].Lancet,2018,391(10134):1985.
[23] LI G,YIN J,GAO J,et al.Subchondral bone in osteoarthritis: insight into risk factors and microstructural changes[J].Arthritis Res Ther,2013,15(6):223.
[24] 李西海,葉蕻芝.從腎通于腦初探下丘腦-垂體-靶腺軸與骨關(guān)節(jié)炎的關(guān)系[J].中華中醫(yī)藥雜志,2019,34(6):2342-2345.
[25] ZHEN G,CAO X.Targeting TGFβ signaling in subchondral bone and articular cartilage homeostasis[J].Trends Pharmacol Sci,2014,35(5):227-236.
[26] CHEN W,SUN Y,GU X,et al.Conditioned medium of mesenchymal stem cells delays osteoarthritis progression in a rat model by protecting subchondral bone, maintaining matrix homeostasis, and enhancing autophagy[J].J Tissue Eng Regen Med,2019,13(9):1618-1628.
[27] SADEGHI F,VAHEDNIA E,NADERI MESHKIN H,et al.The effect of adrenocorticotropic hormone on alpha-2-macroglobulin in osteoblasts derived from human mesenchymal stem cells[J].J Cell Mol Med,2020,24(8):4784-4790.
[28] SUN L,TAMMA R,YUEN T,et al.Functions of vasopressin and oxytocin in bone mass regulation[J].Proc Natl Acad Sci U S A,2016,113(1):164-169.
[29] ZAIDI M,NEW M I,BLAIR H C,et al.Actions of pituitary hormones beyond traditional targets[J].J Endocrinol,2018,237(3):R83-R98.
[30] 袁家駿,羅程,黃毅,等.口服自擬補(bǔ)腎活血湯治療早期膝骨關(guān)節(jié)炎的臨床研究[J].中醫(yī)正骨,2017,29(8):26-32.
[31] 劉源香.髓的中醫(yī)文獻(xiàn)研究[D].濟(jì)南:山東中醫(yī)藥大學(xué),2013.
[32] 孫榮新.右歸飲加減內(nèi)服聯(lián)合玻璃酸鈉關(guān)節(jié)腔內(nèi)注射治療膝骨關(guān)節(jié)炎(脾腎陽虛型)的臨床療效觀察[D].合肥:安徽中醫(yī)藥大學(xué),2018.
[33] 田惠萍,劉瑩,王海洋,等.膝骨關(guān)節(jié)炎的中醫(yī)藥治療臨床研究進(jìn)展[J].風(fēng)濕病與關(guān)節(jié)炎,2018,7(1):67-71.
[34] MCALINDON T E,BANNURU R R,SULLIVAN M C,et al.OARSI guidelines for the non-surgical management of knee osteoarthritis[J].Osteoarthritis Cartilage,2014,22(3):363-388.
[35] OKUMACHI E,LEE S Y,NIIKURA T,et al.Comparative analysis of rat mesenchymal stem cells derived from slow and fast skeletal muscle in vitro[J].Int Orthop,2015,39(3):569-576.
[36] PERS Y M,QUENTIN J,FEIRREIRA R,et al.Injection of adipose-derived stromal cells in the knee of patients with severe osteoarthritis has a systemic effect and promotes an anti-inflammatory phenotype of circulating immune cells[J].Theranostics,2018,8(20):5519-5528.
[37] 張圣揚(yáng),呂帥潔,丁權(quán)威,等.自體脂肪干細(xì)胞關(guān)節(jié)腔內(nèi)注射治療膝關(guān)節(jié)骨關(guān)節(jié)炎的隨機(jī)對照研究[J].中華骨科雜志,2018,38(23):1426-1434.
[38] CHAHAL J,GóMEZ-ARISTIZBAL A,SHESTOPALOFF K,et al.Bone marrow mesenchymal stromal cell treatment in patients with osteoarthritis results in overall improvement in pain and symptoms and reduces synovial inflammation[J].Stem Cells Transl Med,2019,8(8):746-757.
[39] WANG P E,DONG R,WANG B L,et al.Genome-wide microRNA screening reveals miR-582-5p as a mesenchymal stem cell-specific microRNA in subchondral bone of the human knee joint[J].J Cell Physiol,2019,234(12):21877-21888.
[40] NI Z,ZHOU S,LI S,et al.Exosomes:roles and therapeutic potential in osteoarthritis[J].Bone Res,2020,8:25.
[41] LIAN W S,WU R W,LEE M S,et al.Subchondral mesenchymal stem cells from osteoarthritic knees display high osteogenic differentiation capacity through microRNA-29a regulation of HDAC4[J].J Mol Med(Berl),2017,95(12):1327-1340.
相似文獻(xiàn)/References:
[1]樊慶陽,任凱晶.定制3D打印切模輔助全膝關(guān)節(jié)置換術(shù)治療
膝骨關(guān)節(jié)炎合并股骨干骨折畸形愈合[J].中醫(yī)正骨,2015,27(11):37.
[2]劉曉雅,孫永強(qiáng),劉國杰.主動(dòng)快速康復(fù)鍛煉對全膝關(guān)節(jié)置換術(shù)后關(guān)節(jié)活動(dòng)度的影響[J].中醫(yī)正骨,2015,27(09):73.
[3]鄭春松,葉蕻芝,李西海,等.透骨消痛膠囊中補(bǔ)腎柔肝藥和活血祛風(fēng)藥治療
骨關(guān)節(jié)炎作用方式的計(jì)算機(jī)模擬比較[J].中醫(yī)正骨,2015,27(07):6.
ZHENG Chunsong,YE Hongzhi,LI Xihai,et al.Comparison of the mode of action of Bushen Rougan(補(bǔ)腎柔肝)drugs versus Huoxue Qufeng(活血祛風(fēng))drugs contained in Tougu Xiaotong Jiaonang(透骨消痛膠囊)for the treatment of osteoarthritis:A computer simulation study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):6.
[4]宋兵華,孫俊英,倪增良,等.全膝關(guān)節(jié)置換術(shù)前CT測量股骨后髁角的臨床意義[J].中醫(yī)正骨,2015,27(07):38.
[5]鄭春松,葉蕻芝,李西海,等.獨(dú)活寄生湯含藥血清對白細(xì)胞介素1β誘導(dǎo)的
退變關(guān)節(jié)軟骨細(xì)胞中基質(zhì)金屬蛋白酶
和環(huán)氧化酶2表達(dá)的影響[J].中醫(yī)正骨,2015,27(12):1.
ZHENG Chunsong,YE Hongzhi,LI Xihai,et al.Impact of Duhuo Jisheng Tang(獨(dú)活寄生湯)medicated serum on expression of matrix metalloproteinase and cyclooxygenase 2 in degenerative articular chondrocytes induced by interleukin-1 beta[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):1.
[6]王金良,孫京濤,李玲,等.骨水泥聯(lián)合螺釘修復(fù)全膝關(guān)節(jié)置換術(shù)中
脛骨平臺(tái)內(nèi)側(cè)骨缺損[J].中醫(yī)正骨,2015,27(12):55.
[7]馮榮,王平,李炳奇,等.鈹針刺絡(luò)拔罐結(jié)合中藥口服治療膝骨關(guān)節(jié)炎合并
原發(fā)性血小板增多癥1例[J].中醫(yī)正骨,2015,27(12):73.
[8]蔡云仙.圍手術(shù)期耳穴按壓聯(lián)合平衡針療法
在全膝關(guān)節(jié)置換術(shù)后鎮(zhèn)痛中的應(yīng)用[J].中醫(yī)正骨,2015,27(06):41.
[9]張榮,王健.人工全膝關(guān)節(jié)置換術(shù)的圍手術(shù)期心理護(hù)理[J].中醫(yī)正骨,2015,27(05):77.
[10]喻長純,楊明路,王戰(zhàn)朝.不同手術(shù)方式治療脛骨平臺(tái)骨折畸形愈合的體會(huì)[J].中醫(yī)正骨,2015,27(03):37.
[11]孟維娜,明立功,王新德,等.關(guān)節(jié)鏡下清理聯(lián)合腓骨近1/3段截骨治療膝骨關(guān)節(jié)炎[J].中醫(yī)正骨,2015,27(11):40.
[12]明立功,孟維娜,王新德,等.腓骨近端截骨治療內(nèi)側(cè)間室膝骨關(guān)節(jié)炎的近期療效觀察[J].中醫(yī)正骨,2015,27(10):25.
[13]張杰,王人彥,張玉柱.膝骨關(guān)節(jié)炎的治療進(jìn)展[J].中醫(yī)正骨,2015,27(10):68.
[14]梁朝,蔡靜怡,閆立,等.針刀療法改善膝骨關(guān)節(jié)炎早期疼痛癥狀的療效評價(jià)[J].中醫(yī)正骨,2015,27(09):9.
LIANG Zhao,CAI Jingyi,YAN Li,et al.Evaluation of the curative effect of needle-knife therapy for relieving knee pain in patients with early knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):9.
[15]王建武,黨建軍,李強(qiáng),等.四聯(lián)療法治療膝骨關(guān)節(jié)炎[J].中醫(yī)正骨,2015,27(08):44.
[16]劉紅娟,郭會(huì)利,郭樹農(nóng).云克聯(lián)合中藥治療膝骨關(guān)節(jié)炎的護(hù)理[J].中醫(yī)正骨,2015,27(08):75.
[17]陳衛(wèi)衡.探索建立系統(tǒng)的膝骨關(guān)節(jié)炎中醫(yī)臨床科研范式
和理論體系[J].中醫(yī)正骨,2015,27(07):1.
[18]帥波,沈霖,楊艷萍,等.加味青娥丸治療膝骨關(guān)節(jié)炎的作用機(jī)制研究[J].中醫(yī)正骨,2015,27(07):15.
SHUAI Bo,SHEN Lin,YANG Yanping,et al.Study on the mechanism of action of Jiawei Qing'e Wan(加味青娥丸)for the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):15.
[19]梅其杰,袁長深,段戡,等.壯藥骨痹方燙熨聯(lián)合運(yùn)動(dòng)療法治療膝骨關(guān)節(jié)炎的臨床研究[J].中醫(yī)正骨,2015,27(07):27.
MEI Qijie,YUAN Changshen,DUAN Kan,et al.Clinical study of the curative effect of hot compressing and rubbing with packet of Gubi Fang(骨痹方)combined with exercise therapy in the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):27.
[20]王丹輝,張燕,劉麗娟,等.重組人Ⅱ型腫瘤壞死因子受體-抗體融合蛋白
關(guān)節(jié)腔注射聯(lián)合中藥薰洗治療膝骨關(guān)節(jié)炎的臨床研究[J].中醫(yī)正骨,2015,27(07):31.
WANG Danhui,ZHANG Yan,LIU Lijuan,et al.Clinical study on intra-articular injection of TypeⅡrecombinant human tumor necrosis factor receptor-Fc fusion protein combined with Chinese herbal steaming and washing therapy for treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):31.